Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular Dystrophy. (2012)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/mtna.2012.54

PubMed Identifier: 23250360

Publication URI: http://europepmc.org/abstract/MED/23250360

Type: Journal Article/Review

Volume: 1

Parent Publication: Molecular therapy. Nucleic acids

ISSN: 2162-2531